Business Context and Reporting Period
This Form 8-K is a current report filed by E. I. du Pont de Nemours and Company (DuPont) on July 15, 2016, regarding events occurring on July 13, 2016. The filing serves as a Regulation FD disclosure to inform stockholders of the receipt of a letter from the Action Network Fund (ANF).
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a received communication rather than a financial performance report.
Material Changes
There are no material changes to financial results or operations reported in this document. The filing addresses the receipt of an external letter regarding pending and potential litigation, specifically the multi-district litigation (MDL) related to personal injury cases associated with exposure to PFOA.
Guidance, Outlook, and Risks
- ANF Letter Content: The letter from Action Network Fund references various litigation and investigatory matters, including estimates of potential claims, dollar-value exposure, and the enforceability of indemnification claims against The Chemours Company.
- Company Position: DuPont states the ANF Letter was not prepared by or with input from the Company. The Company does not attest to the accuracy or completeness of the letter and may disagree with its characterizations.
- Disclosure Status: DuPont asserts that all information required to be disclosed regarding these matters has already been provided in prior filings, specifically the 2016 Form 10-K, the Q1 2016 Form 10-Q, and a Form 8-K filed on July 8, 2016.
- Legal Disclaimer: The information in this report is furnished under Item 7.01 and is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Facts for Investor Verification
- Verify the content of the ANF Letter (Exhibit 99.1) regarding PFOA MDL exposure estimates.
- Review DuPont's prior disclosures in the February 4, 2016 Form 10-K, April 26, 2016 Form 10-Q, and July 8, 2016 Form 8-K for the Company's official stance on litigation risks.
- Confirm the status of indemnification claims against The Chemours Company as referenced in the ANF Letter.